中外製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/10/11 | 3,737 | 3,748 | 3,676 | 3,699 | -78 | -2.1% | 2,174,600 |
| 2022/10/07 | 3,753 | 3,797 | 3,727 | 3,777 | -24 | -0.6% | 1,943,200 |
| 2022/10/06 | 3,800 | 3,834 | 3,769 | 3,801 | -7 | -0.2% | 2,061,600 |
| 2022/10/05 | 3,812 | 3,829 | 3,765 | 3,808 | +18 | +0.5% | 2,685,800 |
| 2022/10/04 | 3,735 | 3,790 | 3,707 | 3,790 | +120 | +3.3% | 2,710,800 |
| 2022/10/03 | 3,613 | 3,671 | 3,580 | 3,670 | +44 | +1.2% | 2,366,200 |
| 2022/09/30 | 3,637 | 3,679 | 3,608 | 3,626 | -4 | -0.1% | 4,237,200 |
| 2022/09/29 | 3,526 | 3,630 | 3,525 | 3,630 | +150 | +4.3% | 2,832,200 |
| 2022/09/28 | 3,406 | 3,482 | 3,406 | 3,480 | +48 | +1.4% | 4,064,000 |
| 2022/09/27 | 3,425 | 3,459 | 3,411 | 3,432 | +14 | +0.4% | 1,854,900 |
| 2022/09/26 | 3,336 | 3,437 | 3,336 | 3,418 | +15 | +0.4% | 2,599,400 |
| 2022/09/22 | 3,411 | 3,421 | 3,371 | 3,403 | -42 | -1.2% | 1,773,200 |
| 2022/09/21 | 3,467 | 3,492 | 3,437 | 3,445 | -52 | -1.5% | 1,732,400 |
| 2022/09/20 | 3,536 | 3,550 | 3,492 | 3,497 | -37 | -1% | 1,688,800 |
| 2022/09/16 | 3,557 | 3,572 | 3,531 | 3,534 | -31 | -0.9% | 2,201,400 |
| 2022/09/15 | 3,566 | 3,594 | 3,536 | 3,565 | +3 | +0.1% | 1,433,100 |
| 2022/09/14 | 3,541 | 3,594 | 3,534 | 3,562 | -98 | -2.7% | 2,575,300 |
| 2022/09/13 | 3,665 | 3,689 | 3,651 | 3,660 | -4 | -0.1% | 1,287,500 |
| 2022/09/12 | 3,665 | 3,676 | 3,636 | 3,664 | +4 | +0.1% | 1,228,600 |
| 2022/09/09 | 3,631 | 3,675 | 3,608 | 3,660 | +62 | +1.7% | 2,897,600 |
| 2022/09/08 | 3,562 | 3,598 | 3,552 | 3,598 | +90 | +2.6% | 2,236,900 |
| 2022/09/07 | 3,555 | 3,566 | 3,466 | 3,508 | -48 | -1.3% | 2,310,700 |
| 2022/09/06 | 3,550 | 3,604 | 3,549 | 3,556 | -4 | -0.1% | 1,172,400 |
| 2022/09/05 | 3,550 | 3,583 | 3,541 | 3,560 | -33 | -0.9% | 1,005,200 |
| 2022/09/02 | 3,593 | 3,604 | 3,560 | 3,593 | +49 | +1.4% | 2,306,500 |
| 2022/09/01 | 3,560 | 3,579 | 3,535 | 3,544 | -65 | -1.8% | 2,150,200 |
| 2022/08/31 | 3,620 | 3,626 | 3,594 | 3,609 | -49 | -1.3% | 2,698,100 |
| 2022/08/30 | 3,676 | 3,691 | 3,639 | 3,658 | +16 | +0.4% | 1,254,600 |
| 2022/08/29 | 3,615 | 3,653 | 3,615 | 3,642 | -63 | -1.7% | 1,886,300 |
| 2022/08/26 | 3,716 | 3,744 | 3,700 | 3,705 | -18 | -0.5% | 1,280,100 |
| 2022/08/25 | 3,721 | 3,728 | 3,681 | 3,723 | +12 | +0.3% | 1,301,300 |
| 2022/08/24 | 3,733 | 3,740 | 3,706 | 3,711 | -16 | -0.4% | 1,337,200 |
| 2022/08/23 | 3,773 | 3,784 | 3,720 | 3,727 | -93 | -2.4% | 1,754,400 |
| 2022/08/22 | 3,789 | 3,837 | 3,786 | 3,820 | +20 | +0.5% | 1,402,400 |
| 2022/08/19 | 3,839 | 3,857 | 3,797 | 3,800 | -41 | -1.1% | 1,377,000 |
| 2022/08/18 | 3,868 | 3,874 | 3,824 | 3,841 | -38 | -1% | 1,141,500 |
| 2022/08/17 | 3,849 | 3,879 | 3,836 | 3,879 | +14 | +0.4% | 2,095,000 |
| 2022/08/16 | 3,851 | 3,867 | 3,823 | 3,865 | -3 | -0.1% | 1,243,000 |
| 2022/08/15 | 3,885 | 3,890 | 3,853 | 3,868 | +7 | +0.2% | 1,896,500 |
| 2022/08/12 | 3,914 | 3,930 | 3,838 | 3,861 | +77 | +2% | 4,141,800 |
| 2022/08/10 | 3,771 | 3,820 | 3,771 | 3,784 | +1 | ±0% | 1,723,700 |
| 2022/08/09 | 3,808 | 3,842 | 3,775 | 3,783 | +3 | +0.1% | 1,747,900 |
| 2022/08/08 | 3,740 | 3,785 | 3,727 | 3,780 | +10 | +0.3% | 1,361,400 |
| 2022/08/05 | 3,720 | 3,770 | 3,711 | 3,770 | +73 | +2% | 1,911,700 |
| 2022/08/04 | 3,717 | 3,724 | 3,647 | 3,697 | +50 | +1.4% | 2,253,800 |
| 2022/08/03 | 3,647 | 3,666 | 3,616 | 3,647 | +36 | +1% | 2,294,000 |
| 2022/08/02 | 3,750 | 3,770 | 3,610 | 3,611 | -185 | -4.9% | 2,838,400 |
| 2022/08/01 | 3,726 | 3,816 | 3,718 | 3,796 | +62 | +1.7% | 2,847,500 |
| 2022/07/29 | 3,723 | 3,774 | 3,711 | 3,734 | +16 | +0.4% | 3,624,900 |
| 2022/07/28 | 3,742 | 3,742 | 3,632 | 3,718 | +26 | +0.7% | 15,023,400 |
651～
700
件表示中 / 3715件
類似銘柄と比較する
現在ご覧いただいている「中外薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 中外薬 | 761,900円 | +1.7% | +5.0% | 3.28% | 30.58倍 | 6.59倍 |
|
ロシュ傘下で成長続ける異色の医薬品大手。抗体・バイオで先行、抗がん剤、骨・関節領域に強い |
| 武 田 | 429,500円 | -1.1% | +75.3% | 4.66% | 29.42倍 | 0.97倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位１０強入り |
| 第一三共 | 348,500円 | +6.0% | +4.0% | 2.24% | 21.64倍 | 4.00倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
| 大塚ＨＤ | 677,800円 | +2.2% | +10.2% | 1.77% | 13.02倍 | 1.31倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| アステラス薬 | 139,600円 | +0.9% | +380.2% | 5.59% | 19.23倍 | 1.65倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
市場注目の銘柄
チャート関連のコラム
